Clever Leaves and Astrasana Partner to Establish International Supply Agreement For Medical Cannabis Extracts in Czech Republic and Switzerland
TOCANCIPÁ, Colombia, May 30, 2023 (GLOBE NEWSWIRE) — Clever Leaves Holdings Inc. (NASDAQ:CLVR, CLVRW) (“Clever Leaves”), a global medicinal cannabis company, announced today the arrival of the company’s first shipment of medical cannabis extracts from Colombia to Switzerland-based partner, Astrasana Holding AG (“Astrasana”). This marks the first commercial shipment for Clever Leaves to Switzerland, where Astrasana is an established medical cannabis distributor.
Related news for (CLVRW)
- Clever Leaves Announces Voluntary Delisting and SEC Deregistration
- Clever Leaves Reports Fourth Quarter and Full Year 2023 Results
- Clever Leaves and Paradise Seeds to Develop and Register Genetic Assets in Colombia
- Clever Leaves Granted Australian GMP Certification for Cannabis Products by the Therapeutic Goods Administration (TGA)
- Clever Leaves Granted Australian GMP Certification for Cannabis Products by the Therapeutic Goods Administration (TGA)